: ‘: Summary of Revisions’ (2016) 39 Diabetes Care S4
‘A Randomised, 52-Week, Treat-to-Target Trial Comparing Insulin Detemir with Insulin Glargine When Administered as Add-on to Glucose-Lowering Drugs in Insulin-Naive People with Type 2 Diabetes’ <http://link.springer.com.ezproxy4.lib.le.ac.uk/article/10.1007/s00125-007-0911-x/fulltext.html>
Akram J, De Verga V and Group the RS, ‘Insulin Lispro (Lys(B28), Pro(B29)) in the Treatment of Diabetes during the Fasting Month of Ramadan’ (1999) 16 Diabetic Medicine 867
Aldam P, Levy N and Hall GM, ‘Perioperative Management of Diabetic Patients: New Controversies’ (2014) 113 British Journal of Anaesthesia 906
Ali S and others, ‘Guidelines for Managing Diabetes in Ramadan’ (2016) 33 Diabetic Medicine 1315
Anderson B, Funnell M, and American Diabetes Association, The Art of Empowerment: Stories and Strategies for Diabetes Educators (2nd ed, American Diabetes Association 2005)
Anderson JW, Kendall CWC and Jenkins DJA, ‘Importance of Weight Management in Type 2 Diabetes: Review with Meta-Analysis of Clinical Studies’ (2003) 22 Journal of the American College of Nutrition 331
Ashwell SG and others, ‘Improved Glycaemic Control with Insulin Glargine plus Insulin Lispro: A Multicentre, Randomized, Cross-over Trial in People with Type 1 Diabetes’ (2006) 23 Diabetic Medicine 285
Bailey S, Academic Writing: A Handbook for International Students (3rd ed, Routledge 2011) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=310467>
Bajwa S and others, ‘Interdisciplinary Position Statement on Management of Hyperglycemia in Peri-Operative and Intensive Care’ (2015) 31 Journal of Anaesthesiology Clinical Pharmacology
Bakiner O and others, ‘Repaglinide plus Single-Dose Insulin Glargine: A Safe Regimen for Low-Risk Type 2 Diabetic Patients Who Insist on Fasting in Ramadan’ (2009) 46 Acta Diabetologica 63
Barker P and others, ‘Peri-Operative Management of the Surgical Patient with Diabetes 2015’ (2015) 70 Anaesthesia 1427
‘Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia’ (2012) 367 New England Journal of Medicine 319
Benkhadra K and others, ‘Real Time Continuous Glucose Monitoring in Type 1 Diabetes: A Systematic Review and Individual Patient Data Meta-Analysis’ [2016] Clinical Endocrinology
Bergenstal RM and others, ‘Adjust to Target in Type 2 Diabetes: Comparison of a Simple Algorithm with Carbohydrate Counting for Adjustment of Mealtime Insulin Glulisine’ (2008) 31 Diabetes Care 1305
Bergenstal RM and others, ‘Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes’ (2010) 363 New England Journal of Medicine 311
Bergenstal RM and others, ‘A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes’ (2012) 35 Diabetes Care 2140
Bretzel RG and others, ‘Once-Daily Basal Insulin Glargine versus Thrice-Daily Prandial Insulin Lispro in People with Type 2 Diabetes on Oral Hypoglycaemic Agents (APOLLO): An Open Randomised Controlled Trial’ (2008) 371 The Lancet 1073
Burnett JCD, ‘Long‐ and Short‐Haul Travel by Air: Issues for People With Diabetes on Insulin’ (2006) 13 Journal of Travel Medicine 255
Buse JB and others, ‘Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes’ (2011) 154 Annals of Internal Medicine
——, ‘Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)’ (2014) 37 Diabetes Care 2926
‘Clinical Effectiveness and Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion for Diabetes: Systematic Review and Economic Evaluation’ <http://www.journalslibrary.nihr.ac.uk/hta/volume-14/issue-11>
Crasto, W., Handbook of Insulin Therapies (Adis; 1st ed 2016 edition 2016) <https://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4676975>
——, Handbook of Insulin Therapies (Adis; 1st ed 2016 edition 2016) <https://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4676975>
——, Handbook of Insulin Therapies (Adis; 1st ed 2016 edition 2016) <https://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4676975>
——, Handbook of Insulin Therapies (Adis; 1st ed 2016 edition 2016) <https://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4676975>
——, Handbook of Insulin Therapies (Adis; 1st ed 2016 edition 2016) <https://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4676975>
——, Handbook of Insulin Therapies (Adis; 1st ed 2016 edition 2016) <https://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4676975>
Crasto W and others, ‘Insulin U-500 in Severe Insulin Resistance in Type 2 Diabetes Mellitus’ (2009) 85 Postgraduate Medical Journal 219
Daly H and others, ‘Development of a Self-Management Education Module for Those with Type 2 Diabetes on Injectable Therapies’ (2015) 32 Practical Diabetes 305
Davies M and others, ‘Improvement of Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes: Comparison of Two Treatment Algorithms Using Insulin Glargine’ (2005) 28 Diabetes Care 1282
——, ‘Improvement of Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes: Comparison of Two Treatment Algorithms Using Insulin Glargine’ (2005) 28 Diabetes Care 1282
Davies MJ and others, ‘Exenatide Compared with Long-Acting Insulin to Achieve Glycaemic Control with Minimal Weight Gain in Patients with Type 2 Diabetes: Results of the Helping Evaluate Exenatide in Patients with Diabetes Compared with Long-Acting Insulin (HEELA) Study’ (2009) 11 Diabetes, Obesity and Metabolism 1153
——, ‘Efficacy and Safety of Insulin Degludec given as Part of Basal-Bolus Treatment with Mealtime Insulin Aspart in Type 1 Diabetes: A 26-Week Randomized, Open-Label, Treat-to-Target Non-Inferiority Trial’ (2014) 16 Diabetes, Obesity and Metabolism 922
——, ‘Impact of Baseline HbA1c, Diabetes Duration and BMI on Clinical Outcomes in the LixiLan-O Trial Testing iGlarLixi (Insulin Glargine/Lixisenatide Titratable Fixed-Ratio Combination) versus Insulin Glargine and Lixisenatide Monocomponents’ [2017] Diabetes, Obesity and Metabolism
Davies MJ and Chatterjee S, ‘Trial Watch: Insulin Initiation for Type 2 Diabetes Mellitus in Primary Care’ (2017) 13 Nature Reviews Endocrinology 317
‘Diabetes & Metabolism - Présentation - EM Consulte’ <http://www.em-consulte.com/article/80031/alertePM#N1010C>
Diamant M and others, ‘Once Weekly Exenatide Compared with Insulin Glargine Titrated to Target in Patients with Type 2 Diabetes (DURATION-3): An Open-Label Randomised Trial’ (2010) 375 The Lancet 2234
‘EASD Virtual Meeting’ <http://www.easdvirtualmeeting.org/resources/systematic-review-and-meta-analysis-of-the-efficacy-and-safety-of-sglt2-inhibitors-in-patients-with-type-2-diabetes-mellitus>
‘Effects of Intensive Glucose Lowering in Type 2 Diabetes’ (2008) 358 New England Journal of Medicine 2545
‘Efficacy and Safety of a Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Compared with Its Components given Alone: Results of a Phase 3, Open-Label, Randomised, 26-Week, Treat-to-Target Trial in Insulin-Naive Patients with Type 2 Diabetes - ClinicalKey’ <https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858714701743>
‘Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes Systematic Review and Mixed-Treatment Comparison Analysis’ <http://onlinelibrary.wiley.com.ezproxy3.lib.le.ac.uk/doi/10.1111/dom.12849/epdf>
Eng C and others, ‘Glucagon-like Peptide-1 Receptor Agonist and Basal Insulin Combination Treatment for the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis’ (2014) 384 The Lancet 2228
Evans M and others, ‘A Review of Modern Insulin Analogue Pharmacokinetic and Pharmacodynamic Profiles in Type 2 Diabetes: Improvements and Limitations’ (2011) 13 Diabetes, Obesity and Metabolism 677
F Game, ‘Annals of The Royal College of Surgeons of England’ (2012) 94 <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954366/?report=classic>
Fineman MS and others, ‘GLP-1 Based Therapies: Differential Effects on Fasting and Postprandial Glucose’ (2012) 14 Diabetes, Obesity and Metabolism 675
Frandsen CSS and Madsbad S, ‘Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors as an Add-on to Insulin Treatment in Patients with Type 2 Diabetes: A Review’ (2014) 31 Diabetic Medicine 1293
——, ‘Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors as an Add-on to Insulin Treatment in Patients with Type 2 Diabetes: A Review’ (2014) 31 Diabetic Medicine 1293
Frisch A and others, ‘Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery’ (2010) 33 Diabetes Care 1783
Fullerton B and others, ‘Intensive Glucose Control versus Conventional Glucose Control for Type 1 Diabetes Mellitus’, Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd 1996) <http://doi.wiley.com/10.1002/14651858.CD009122.pub2>
Garber AJ and others, ‘Attainment of Glycaemic Goals in Type 2 Diabetes with Once-, Twice-, or Thrice-Daily Dosing with Biphasic Insulin Aspart 70/30 (The 1-2-3 Study)’ (2006) 8 Diabetes, Obesity and Metabolism 58
Garber AJ and others, ‘Premixed Insulin Treatment for Type 2 Diabetes: Analogue or Human?’ (2007) 9 Diabetes, Obesity and Metabolism 630
Giugliano D and others, ‘Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials’ (2011) 34 Diabetes Care 510
Goudswaard AN and others, ‘Insulin Monotherapy versus Combinations of Insulin with Oral Hypoglycaemic Agents in Patients with Type 2 Diabetes Mellitus’, Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd 1996) <http://doi.wiley.com/10.1002/14651858.CD003418.pub2>
Gough SCL and others, ‘Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naive Patients With Type 2 Diabetes: A 26-Week, Randomized, Controlled, Multinational, Treat-to-Target Trial: The BEGIN LOW VOLUME Trial’ (2013) 36 Diabetes Care 2536
Gregory T. Mucha,Stacia Merkel,William Thomas,John P. Bantle, ‘Fasting and Insulin Glargine in Individuals with Type 1 Diabetes’ Diabetes Care <http://go.galegroup.com.ezproxy4.lib.le.ac.uk/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=17&docId=GALE%7CA116666633&docType=Article&sort=Relevance&contentSegment=&prodId=EAIM&contentSet=GALE%7CA116666633&searchId=R8&userGroupName=leicester&inPS=true>
Guevara-Aguirre J and others, ‘Beneficial Effects of Addition of Oral Spray Insulin (Oralin) on Insulin Secretion and Metabolic Control in Subjects with Type 2 Diabetes Mellitus Suboptimally Controlled on Oral Hypoglycemic Agents’ (2004) 6 Diabetes Technology & Therapeutics 1
Gururaj Setty S and others, ‘New Insulins and Newer Insulin Regimens: A Review of Their Role in Improving Glycaemic Control in Patients with Diabetes’ (2016) 92 Postgraduate Medical Journal 152
Gurwitz JH, ‘Glucocorticoids and the Risk for Initiation of Hypoglycemic Therapy’ (1994) 154 Archives of Internal Medicine
Hannele Yki-Järvinen, ‘Is There Evidence to Support Use of Premixed or Prandial Insulin Regimens in Insulin-Naive or Previously Insulin-Treated Type 2 Diabetic Patients?’ (2013) 36 Diabetes Care <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920773/>
Hannele Yki-Jarvinen,Leena Juurinen,Michael Alvarsson,Tord Bystedt,Ian Caldwell,Melanie Davies, ‘Initiate Insulin by Aggressive Titration and Education (Initiate): Randomized Study to Compare Initiation of Insulin Combination Therapy in Type 2 Diabetic Patients Individually and in Groups’ Diabetes Care <http://go.galegroup.com.ezproxy4.lib.le.ac.uk/ps/retrieve.do?sort=DA-SORT&docType=Clinical+report&tabID=T002&prodId=EAIM&searchId=R1&resultListType=RESULT_LIST&searchType=AdvancedSearchForm&contentSegment=&currentPosition=5&searchResultsType=SingleTab&inPS=true&userGroupName=leicester&docId=GALE%7CA165017903&contentSet=GALE%7CA165017903>
Heller S and others, ‘Insulin Degludec, an Ultra-Longacting Basal Insulin, versus Insulin Glargine in Basal-Bolus Treatment with Mealtime Insulin Aspart in Type 1 Diabetes (BEGIN Basal-Bolus Type 1): A Phase 3, Randomised, Open-Label, Treat-to-Target Non-Inferiority Trial’ (2012) 379 The Lancet 1489
Heller SR and others, ‘Hypoglycaemia with Insulin Aspart: A Double-Blind, Randomised, Crossover Trial in Subjects with Type 1 Diabetes’ (2004) 21 Diabetic Medicine 769
Hermansen K and others, ‘A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes’ (2006) 29 Diabetes Care 1269
Hermansen K and Davies M, ‘Does Insulin Detemir Have a Role in Reducing Risk of Insulin-Associated Weight Gain?’ (2007) 9 Diabetes, Obesity and Metabolism 209
Hirsch IB and others, ‘Options for Prandial Glucose Management in Type 2 Diabetes Patients Using Basal Insulin: Addition of a Short-Acting GLP-1 Analogue versus Progression to Basal-Bolus Therapy’ (2014) 16 Diabetes, Obesity and Metabolism 206
——, ‘Safety and Efficacy of Insulin Degludec/Insulin Aspart with Bolus Mealtime Insulin Aspart Compared with Standard Basal-Bolus Treatment in People with Type 1 Diabetes: 1-Year Results from a Randomized Clinical Trial (BOOST T1)’ (2017) 34 Diabetic Medicine 167
Holman RR and others, ‘Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes’ (2007) 357 New England Journal of Medicine 1716
——, ‘Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes’ (2007) 357 New England Journal of Medicine 1716
——, ‘10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes’ (2008) 359 New England Journal of Medicine 1577
——, ‘Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes’ (2009) 361 New England Journal of Medicine 1736
——, ‘Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes’ (2009) 361 New England Journal of Medicine 1736
——, ‘Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes’ (2009) 361 New England Journal of Medicine 1736
Holman RR and Turner RC, ‘A Practical Guide to Basal and Prandial Insulin Therapy’ (1985) 2 Diabetic Medicine 45
Holt RIG, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
Home P and others, ‘Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?’ (2014) 37 Diabetes Care 1499
Home PD, ‘The Pharmacokinetics and Pharmacodynamics of Rapid-Acting Insulin Analogues and Their Clinical Consequences’ (2012) 14 Diabetes, Obesity and Metabolism 780
Home PD and others, ‘New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)’ (2015) 38 Diabetes Care 2217
Hommel I and others, ‘Perioperative Diabetes Care: Room for Improving the Person Centredness’ (2015) 32 Diabetic Medicine 561
Horvath K and others, ‘Long-Acting Insulin Analogues versus NPH Insulin (Human Isophane Insulin) for Type 2 Diabetes Mellitus’, Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd 1996) <http://doi.wiley.com/10.1002/14651858.CD005613.pub3>
——, ‘Long-Acting Insulin Analogues versus NPH Insulin (Human Isophane Insulin) for Type 2 Diabetes Mellitus’, Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd 1996) <http://doi.wiley.com/10.1002/14651858.CD005613.pub3>
Hui E and others, ‘Comparison of Humalog Mix 50 with Human Insulin Mix 30 in Type 2 Diabetes Patients during Ramadan’ (2010) 64 International Journal of Clinical Practice 1095
——, ‘Comparison of Humalog Mix 50 with Human Insulin Mix 30 in Type 2 Diabetes Patients during Ramadan’ (2010) 64 International Journal of Clinical Practice 1095
Hwang JL and Weiss RE, ‘Steroid-Induced Diabetes: A Clinical and Molecular Approach to Understanding and Treatment’ (2014) 30 Diabetes/Metabolism Research and Reviews 96
‘Hyperglycemia and Adverse Pregnancy Outcomes’ (2008) 358 New England Journal of Medicine 1991
‘Insulin Glargine or NPH Combined with Metformin in Type 2 Diabetes: The LANMET Study’ <http://link.springer.com.ezproxy4.lib.le.ac.uk/article/10.1007/s00125-005-0132-0/fulltext.html>
‘Insulin Treatment and the Problem of Weight Gain in Type 2 Diabetes. - PubMed - NCBI’ <http://www.ncbi.nlm.nih.gov/pubmed/17102158>
‘Intensity of Peri-Operative Glycemic Control and Postoperative Outcomes in Patients with Diabetes: A Meta-Analysis - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0168822713001873>
Ismail-Beigi F, ‘Glycemic Management of Type 2 Diabetes Mellitus’ (2012) 366 New England Journal of Medicine 1319
Jackson MJ and others, ‘Perioperative Management of Diabetes in Elective Patients: A Region-Wide Audit’ (2016) 116 British Journal of Anaesthesia 501
Jenkins K, ‘II. Needle Phobia: A Psychological Perspective’ (2014) 113 British Journal of Anaesthesia 4
June James, ‘End-of-Life Care: Anything but a Pathway’ <http://www.diabetesandprimarycare.co.uk/media/content/_master/3572/files/pdf/dpc15-6-292-7.pdf>
——, ‘Safety and Insulin: Implementation of National Guidance at a Local Level’ Journal of Diabetes Nursing <http://go.galegroup.com.ezproxy4.lib.le.ac.uk/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=8&docId=GALE%7CA342482979&docType=Article&sort=RELEVANCE&contentSegment=&prodId=EAIM&contentSet=GALE%7CA342482979&searchId=R6&userGroupName=leicester&inPS=true>
Kahler P and others, ‘Targeting Intensive versus Conventional Glycaemic Control for Type 1 Diabetes Mellitus: A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomised Clinical Trials’ (2014) 4 BMJ Open e004806
Khedkar A and others, ‘A Dose Range Finding Study of Novel Oral Insulin (IN-105) under Fed Conditions in Type 2 Diabetes Mellitus Subjects’ (2010) 12 Diabetes, Obesity and Metabolism 659
Kramer CK, Zinman B and Retnakaran R, ‘Short-Term Intensive Insulin Therapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis’ (2013) 1 The Lancet Diabetes & Endocrinology 28
Kuhlmann M and Marre M, ‘Lessons Learned from Biosimilar Epoetins and Insulins’ (2010) 10 The British Journal of Diabetes & Vascular Disease 90
Kutz A and others, ‘The Association of Admission Hyperglycaemia and Adverse Clinical Outcome in Medical Emergencies: The Multinational, Prospective, Observational TRIAGE Study’ [2017] Diabetic Medicine
L. Luzi, ‘Effect of Loss of First-Phase Insulin Secretion on Hepatic Glucose Production and Tissue Glucose Disposal in Humans’ (1989) 257 American Journal of Physiology - Endocrinology and Metabolism E241 <http://ajpendo.physiology.org.ezproxy4.lib.le.ac.uk/content/257/2/E241>
Lambert K and Holt RIG, ‘The Use of Insulin Analogues in Pregnancy’ (2013) 15 Diabetes, Obesity and Metabolism 888
Lankisch MR and others, ‘Introducing a Simplified Approach to Insulin Therapy in Type 2 Diabetes: A Comparison of Two Single-Dose Regimens of Insulin Glulisine plus Insulin Glargine and Oral Antidiabetic Drugs’ [2008] Diabetes, Obesity and Metabolism
Lasserson DS and others, ‘Optimal Insulin Regimens in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analyses’ (2009) 52 Diabetologia 1990
——, ‘Optimal Insulin Regimens in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analyses’ (2009) 52 Diabetologia 1990
Lea, Mary R. Creme, Phyllis, Writing At University (3rd edn, McGraw-Hill Education 2008) <http://ebookcentral.proquest.com.ezproxy3.lib.le.ac.uk/lib/leicester/detail.action?docID=345134>
Levy N, Penfold N and Mythen M, ‘Perioperative Management of Diabetes and the Emerging Role of Anaesthetists as Perioperative Physicians’ (2016) 116 British Journal of Anaesthesia 443
Liu D and others, ‘A Practical Guide to the Monitoring and Management of the Complications of Systemic Corticosteroid Therapy’ (2013) 9 Allergy, Asthma & Clinical Immunology
Luc JC van Loon, ‘Plasma Insulin Responses after Ingestion of Different Amino Acid or Protein Mixtures with Carbohydrate’ (2000) 72 The American Journal of Clinical Nutrition 96 <http://ajcn.nutrition.org/content/72/1/96.full>
Luzio SD and others, ‘The Glucose Lowering Effect of an Oral Insulin (Capsulin) during an Isoglycaemic Clamp Study in Persons with Type 2 Diabetes’ (2010) 12 Diabetes, Obesity and Metabolism 82
Manju Chandran,Steven V. Edelman, ‘Have Insulin, Will Fly: Diabetes Management during Air Travel and Time Zone Adjustment Strategies. (Practical Pointers)’ Clinical Diabetes <http://go.galegroup.com.ezproxy3.lib.le.ac.uk/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=3&docId=GALE%7CA100730300&docType=Article&sort=Relevance&contentSegment=&prodId=EAIM&contentSet=GALE%7CA100730300&searchId=R2&userGroupName=leicester&inPS=true>
Martha M. Funnell, ‘Overcoming Barriers to the Initiation of Insulin Therapy’ Clinical Diabetes <http://go.galegroup.com.ezproxy3.lib.le.ac.uk/ps/retrieve.do?sort=DA-SORT&docType=Article&tabID=T002&prodId=EAIM&searchId=R1&resultListType=RESULT_LIST&searchType=AdvancedSearchForm&contentSegment=&currentPosition=8&searchResultsType=SingleTab&inPS=true&userGroupName=leicester&docId=GALE%7CA159389875&contentSet=GALE%7CA159389875>
Matthew C. Riddle,Julio Rosenstock,John Gerich, ‘The Treat-to-Target Trial: Randomized Addition of Glargine or Human NPH Insulin to Oral Therapy of Type 2 Diabetic Patients’ Diabetes Care <http://go.galegroup.com.ezproxy4.lib.le.ac.uk/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=9&docId=GALE%7CA110470954&docType=Article&sort=Relevance&contentSegment=&prodId=EAIM&contentSet=GALE%7CA110470954&searchId=R3&userGroupName=leicester&inPS=true>
Mattoo V and others, ‘A Comparison of Insulin Lispro Mix25TM and Human Insulin 30/70 in the Treatment of Type 2 Diabetes during Ramadan’ (2003) 59 Diabetes Research and Clinical Practice 137
McBain H and others, ‘Barriers to and Enablers of Insulin Self-Titration in Adults with Type 2 Diabetes: A Qualitative Study’ (2017) 34 Diabetic Medicine 253
McCrimmon RJ, ‘Old Habits Are Hard to Break: Lessons from the Study of Hypoglycaemia’ (2017) 34 Diabetic Medicine 148
Menting JG and others, ‘How Insulin Engages Its Primary Binding Site on the Insulin Receptor’ (2013) 493 Nature 241
Mollema ED and others, ‘Phobia of Self-Injecting and Self-Testing in Insulin-Treated Diabetes Patients: Opportunities for Screening’ (2001) 18 Diabetic Medicine 671
Morçöl T and others, ‘Calcium Phosphate-PEG-Insulin-Casein (CAPIC) Particles as Oral Delivery Systems for Insulin’ (2004) 277 International Journal of Pharmaceutics 91
Nathan DM, ‘The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview’ (2014) 37 Diabetes Care 9
Nathan DM and others, ‘Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement from the American Diabetes Association and the European Association for the Study of Diabetes’ (2006) 29 Diabetes Care 1963
Nauck M, ‘Incretin Therapies: Highlighting Common Features and Differences in the Modes of Action of Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors’ (2016) 18 Diabetes, Obesity and Metabolism 203
‘New IDegLira Data Show Rapid and Predictable Glycaemic Improvements in People with Type 2 Diabetes’ <http://www.multivu.com/players/English/72762519-novo-nordisk-IDegLira-treatment/>
‘New Insulin Glargine 300 U/mL: Glycemic Control and Hypoglycemia in a Meta-Analysis of Phase 3a EDITION Clinical Trials in People with T2DM - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S1499267114003086>
Owens DR, ‘Stepwise Intensification of Insulin Therapy in Type 2 Diabetes Management-Exploring the Concept of the Basal-plus Approach in Clinical Practice’ (2013) 30 Diabetic Medicine 276
——, ‘Effects of Initiation and Titration of a Single Pre-Prandial Dose of Insulin Glulisine While Continuing Titrated Insulin Glargine in Type 2 Diabetes: A 6-Month ‘proof-of-Concept’ Study’ (2011) 13 Diabetes, Obesity and Metabolism 1020
P. Schneiter, ‘Kinetics of Dexamethasone-Induced Alterations of Glucose Metabolism in Healthy Humans’ (1998) 275 American Journal of Physiology - Endocrinology and Metabolism E806 <http://ajpendo.physiology.org/content/275/5/E806>
Park SW and others, ‘Insulin Degludec/Insulin Aspart Once Daily in Type 2 Diabetes: A Comparison of Simple or Stepwise Titration Algorithms (BOOST : SIMPLE USE)’ (2017) 34 Diabetic Medicine 174
Peter Mansell, ‘The Dose Adjustment for Normal Eating (DAFNE) Education Programme’ Journal of Diabetes Nursing <http://go.galegroup.com.ezproxy4.lib.le.ac.uk/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=1&docId=GALE%7CA314268073&docType=Article&sort=Relevance&contentSegment=&prodId=EAIM&contentSet=GALE%7CA314268073&searchId=R1&userGroupName=leicester&inPS=true>
Philip Raskin,Elsie Allen,Priscilla Hollander,Andrew Lewin,Robert A. Gabbay,Peter Hu, ‘Initiating Insulin Therapy in Type 2 Diabetes: A Comparison of Biphasic and Basal Insulin Analogs’ Diabetes Care <http://go.galegroup.com.ezproxy4.lib.le.ac.uk/ps/retrieve.do?sort=DA-SORT&docType=Article&tabID=T002&prodId=EAIM&searchId=R5&resultListType=RESULT_LIST&searchType=AdvancedSearchForm&contentSegment=&currentPosition=5&searchResultsType=SingleTab&inPS=true&userGroupName=leicester&docId=GALE%7CA128867472&contentSet=GALE%7CA128867472>
Pickup JC, Reznik Y and Sutton AJ, ‘Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-Analysis and Meta-Regression of Randomized Controlled Trials’ (2017) 40 Diabetes Care 715
Pozzilli P and others, ‘Biokinetics of Buccal Spray Insulin in Patients with Type 1 Diabetes’ (2005) 54 Metabolism 930
‘Prandial Inhaled Insulin plus Basal Insulin Glargine versus Twice Daily Biaspart Insulin for Type 2 Diabetes: A Multicentre Randomised Trial - ClinicalKey’ <https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S0140673610606320>
‘Professor Kamlesh Khunti - Coding, Classification and Diagnosis of Diabetes’ <https://www.youtube.com/watch?v=AhhWTmEFuag>
Raccah D and others, ‘Review of Basal-plus Insulin Regimen Options for Simpler Insulin Intensification in People with Type 2 Diabetes Mellitus’ [2017] Diabetic Medicine
——, ‘Review of Basal-plus Insulin Regimen Options for Simpler Insulin Intensification in People with Type 2 Diabetes Mellitus’ [2017] Diabetic Medicine
——, ‘Review of Basal-plus Insulin Regimen Options for Simpler Insulin Intensification in People with Type 2 Diabetes Mellitus’ (2017) 34 Diabetic Medicine 1193
——, ‘Review of Basal-plus Insulin Regimen Options for Simpler Insulin Intensification in People with Type 2 Diabetes Mellitus’ (2017) 34 Diabetic Medicine 1193
‘Randomized Controlled Trial of Insulin Detemir versus NPH for the Treatment of Pregnant Women with Diabetes - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0002937815005931>
Richter B and Neises G, ‘“Human” Insulin versus Animal Insulin in People with Diabetes Mellitus’, Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd 1996) <http://doi.wiley.com/10.1002/14651858.CD003816.pub2>
Riddle MC and others, ‘Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-Week, Randomized, Placebo-Controlled Comparison (GetGoal-L)’ (2013) 36 Diabetes Care 2489
——, ‘Randomized, 1-Year Comparison of Three Ways to Initiate and Advance Insulin for Type 2 Diabetes: Twice-Daily Premixed Insulin versus Basal Insulin with Either Basal-plus One Prandial Insulin or Basal-Bolus up to Three Prandial Injections’ (2014) 16 Diabetes, Obesity and Metabolism 396
Riddle MC and others, ‘New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)’ (2014) 37 Diabetes Care 2755
Rodbard HW and others, ‘Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) Added to Sulphonylurea Alone or to Sulphonylurea and Metformin in Insulin-Naïve People with Type 2 Diabetes: The DUAL IV Trial’ (2017) 34 Diabetic Medicine 189
Rorsman P and Renstr�m E, ‘Insulin Granule Dynamics in Pancreatic Beta Cells’ (2003) 46 Diabetologia 1029
Rosenstock J and others, ‘Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: A Randomized, Crossover Study’ (2013) 36 Diabetes Care 522
——, ‘Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-Week, Randomized, Open-Label, Active-Controlled Study (GetGoal-X)’ (2013) 36 Diabetes Care 2945
Rosenstock J and others, ‘Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes’ (2014) 37 Diabetes Care 1815
——, ‘Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes’ (2014) 37 Diabetes Care 1815
Rowles S, Kilvert A and Sinclair A, ‘ABCD Position Statement on Diabetes and End of Life Care’ (2011) 28 Practical Diabetes International 26
——, ‘ABCD Position Statement on Diabetes and End of Life Care’ (2011) 28 Practical Diabetes International 26
Russell-Jones D and Khan R, ‘Insulin-Associated Weight Gain in Diabetes – Causes, Effects and Coping Strategies’ (2007) 9 Diabetes, Obesity and Metabolism 799
Shosuke Satake,Mary Courtney Moore,Kayano Igawa,Margaret Converse,Benjamin Farmer,Doss W. Neal, ‘Direct and Indirect Effects of Insulin on Glucose Uptake and Storage by the Liver. (Original Articles)’ Diabetes <http://go.galegroup.com.ezproxy4.lib.le.ac.uk/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=2&docId=GALE%7CA87347789&docType=Article&sort=Relevance&contentSegment=&prodId=EAIM&contentSet=GALE%7CA87347789&searchId=R8&userGroupName=leicester&inPS=true>
Simmons JH and others, ‘Reliability of the Diabetes Fear of Injecting and Self-Testing Questionnaire in Pediatric Patients With Type 1 Diabetes’ (2007) 30 Diabetes Care 987
Simmons LR and others, ‘Steroid-Induced Diabetes: Is It Just Unmasking of Type 2 Diabetes?’ (2012) 2012 ISRN Endocrinology 1
Srinivasan BT and others, ‘Recent Advances in the Management of Type 2 Diabetes Mellitus: A Review’ (2008) 84 Postgraduate Medical Journal 524
Srinivasan BT and Davies M, ‘Glycaemic Management of Type 2 Diabetes’ (2014) 42 Medicine 711
‘Suggested Insulin Regimens for Patients with Type 1 Diabetes Mellitus Who Wish to Fast during the Month of Ramadan - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0149291808002737>
Swinnen SG and others, ‘Insulin Detemir versus Insulin Glargine for Type 2 Diabetes Mellitus’, Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd 1996) <http://doi.wiley.com/10.1002/14651858.CD006383.pub2>
Tapley M and Needham E, ‘Improving End of Life Care for People with Diabetes’ (2012) 29 Practical Diabetes 306
‘The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus’ (1993) 329 New England Journal of Medicine 977
Tikkanen-Dolenc H and others, ‘Frequent and Intensive Physical Activity Reduces Risk of Cardiovascular Events in Type 1 Diabetes’ [2016] Diabetologia
‘Training in Flexible, Intensive Insulin Management to Enable Dietary Freedom in People with Type 1 Diabetes: Dose Adjustment for Normal Eating (DAFNE) Randomised Controlled Trial’ (2002) 325 BMJ 746
Villani M, de Courten B and Zoungas S, ‘Emergency Treatment of Hypoglycaemia: A Guideline and Evidence Review’ (2017) 34 Diabetic Medicine 1205
W. Blair Geho, ‘A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral Hepatic-Directed Vesicle Insulin Add-on to Oral Antidiabetic Treatment in Patients With Type 2 Diabetes Mellitus’ (2014) 8 Journal of Diabetes Science and Technology <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455427/>
Wahren J and Kallas A, ‘Loss of Pulsatile Insulin Secretion: A Factor in the Pathogenesis of Type 2 Diabetes?’ (2012) 61 Diabetes 2228
Walker RA, Rodgers J, and Diabetes UK., Diabetes: A Practical Guide to Managing Your Health (Fully revised and updated, Dorling Kindersley 2010)
Wang C, Mamza J and Idris I, ‘Biphasic vs Basal Bolus Insulin Regimen in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials’ (2015) 32 Diabetic Medicine 585
Wang W and others, ‘Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis’ [2017] Diabetes Therapy
Yki-Jarvinen H and others, ‘Initiate Insulin by Aggressive Titration and Education (INITIATE): A Randomized Study to Compare Initiation of Insulin Combination Therapy in Type 2 Diabetic Patients Individually and in Groups’ (2007) 30 Diabetes Care 1364
Yki-Jarvinen H and Kotronen A, ‘Is There Evidence to Support Use of Premixed or Prandial Insulin Regimens in Insulin-Naive or Previously Insulin-Treated Type 2 Diabetic Patients?’ (2013) 36 Diabetes Care S205
Young LA and Buse JB, ‘GLP-1 Receptor Agonists and Basal Insulin in Type 2 Diabetes’ (2014) 384 The Lancet 2180
Zambanini A and others, ‘Injection Related Anxiety in Insulin-Treated Diabetes’ (1999) 46 Diabetes Research and Clinical Practice 239
Zinman B and others, ‘Insulin Degludec, an Ultra-Long-Acting Basal Insulin, Once a Day or Three Times a Week versus Insulin Glargine Once a Day in Patients with Type 2 Diabetes: A 16-Week, Randomised, Open-Label, Phase 2 Trial’ (2011) 377 The Lancet 924
